ArticleExperimental physiology2026
Dendritic cell-specific hypoxia-inducible factor-1α deficiency protects mice from recurrent retroviral infection.
Article in Experimental physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dendritic cell-specific hypoxia-inducible factor-1α deficiency protects mice from recurrent retroviral infection.Experimental physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Antigen-processing and -presenting cells play a pivotal role in initiation of the antiviral immune response. The cellular adaption of dendritic cells to reduced oxygen and nutrition levels at the site of infection is regulated predominantly by the transcription factor complex hypoxia-inducible factor-1 (HIF-1). For a better understanding of the influence of dendritic HIF-1 on the outcome of a retroviral infection, we infected wild-type and CD11c-specific HIF-1α knockout mice with the murine Friend leukaemia virus (FV) to cause an acute to chronic infection. Chronic FV infection caused a much more severe clinical course in control mice than in knockout mice, although no gross differences in spleen weight and immune cell population during acute FV infection were observed. Following chronic FV infection, half of the control mice developed massive splenomegaly accompanied by a complete loss of splenic architecture, whereas the remaining control mice appeared able to control viral replication. In contrast, without exception all knockout mice were able to restrict viral replication. Furthermore, control mice showed increased numbers of antigen-presenting cells with impaired activation and decreased adaptive immune response. Given that our knockout construct leads to an HIF-1α protein without a functional DNA binding domain, and it was already shown that HIF-1α plays a non-transcriptional role in DNA replication, we analysed basal HIF-1α mRNA expression. All animals with a very low basal HIF-1α expression incurred FV recurrence, whereas higher basal expression was protective against recurrence. These results might indicate a novel role of HIF-1α in control of chronic viral infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.